BeStock  
Stocks › Biotechnology › RIGL

Rigel Pharmaceuticals RIGL

US equityMarket cap rank #3339Biotechnology
$40.09 −$1.10 (-2.67%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $40.00 -0.22%
Open$40.65
Prev close$41.19
Day range$39.62 – $41.66
Volume352.2K
Market cap$754.89M
P/E (TTM)2.5
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$80.89M+16.5% YoY
Operating profit$17.11M-39.8% YoY
Net profit$13.19M-52.7% YoY
Diluted EPS$0.65-55.5% YoY
Free cash flow$34.35M+43.0% YoY
Operating cash flow$34.56M

Revenue, last 8 quarters

$57.6MDec '24$53.3MMar '25$101.7MJun '25$69.5MSep '25$69.8MDec '25$58.8MMar '26$78.7MJun '26$80.9MSep '26

Net profit, last 8 quarters

$14.3MDec '24$11.4MMar '25$59.6MJun '25$27.9MSep '25$268.1MDec '25$8.7MMar '26$17.3MJun '26$13.2MSep '26

Diluted EPS by quarter

0.80Dec '240.63Mar '253.28Jun '251.46Sep '2513.54Dec '250.44Mar '260.88Jun '260.65Sep '26

Free cash flow by quarter

$14.5MDec '24$-893.0KMar '25$30.5MJun '25$24.0MSep '25$22.0MDec '25$2.7MMar '26$-39.7MJun '26$34.3MSep '26

Annual revenue

$108.6MFY20$149.2MFY21$120.2MFY22$116.9MFY23$179.3MFY24$294.3MFY25

Profitability & balance sheet

Gross margin89.6%
Operating margin26.3%
Net margin106.6%
Return on equity109.2%
Return on assets80.2%
Return on invested capital97.4%
Current ratio2.39
Liabilities / assets15.0%
Cash & investments$99.31M
Total debt$7.24M
Net cash (debt)$92.07M
Free cash flow / sales6.7%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $80.89M $78.70M $58.82M $294.28M $69.80M
Total Operating Revenue $80.89M $78.70M $58.82M $294.28M $69.80M
Cost of Revenue $10.78M $8.53M $4.61M $19.62M $5.96M
Gross Profit $70.11M $70.18M $54.21M $274.66M $63.85M
Operating Expense $53.00M $46.60M $42.33M $149.20M $40.68M
Selling and Admin Expenses $34.73M $32.64M $30.65M $115.90M $29.99M
Research & Development $18.27M $13.96M $11.68M $33.30M $10.69M
Operating Profit $17.11M $23.58M $11.89M $125.47M $23.17M
Net Non-Operating Interest Income (Expense) $304,000.00 $10,000.00 -$228,000.00 -$3.64M -$456,000.00
Non-Operating Interest Income $561,000.00 $789,000.00 $1.21M $3.68M $1.24M
Non-Operating Interest Expense $257,000.00 $779,000.00 $1.43M $7.32M $1.70M
Pretax Profit $17.41M $23.59M $11.66M $121.83M $22.71M
Tax $4.22M $6.30M $3.00M -$245.20M -$245.35M
Net Profit $13.19M $17.29M $8.65M $367.02M $268.07M
Profit from Continuing Operations $13.19M $17.29M $8.65M $367.02M $268.07M
Net Income to Parent Company $13.19M $17.29M $8.65M $367.02M $268.07M
Net Income to Common Stockholders $13.19M $17.29M $8.65M $367.02M $268.07M
Basic EPS $0.70 $0.93 $0.47 $20.40 $14.72
Diluted EPS $0.65 $0.88 $0.44 $19.48 $13.54

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $523.88M $521.07M $504.61M $513.59M $513.59M
Total Current Assets $188.52M $185.53M $234.03M $240.17M $240.17M
Cash and Cash Equivalents & Short-Term Investments $99.31M $95.33M $146.68M $154.96M $154.96M
-Cash and Cash Equivalents $46.65M $60.82M $24.41M $40.58M $40.58M
-Short Term Investments $52.66M $34.51M $122.27M $114.38M $114.38M
Receivables $56.46M $56.04M $49.95M $51.76M $51.76M
-Accounts Receivable $56.46M $56.04M $49.95M $51.76M $51.76M
Prepaid Assets $10.46M $14.77M $18.61M $16.74M $16.74M
Inventory $15.81M $14.37M $11.65M $11.51M $11.51M
Other Current Assets $6.49M $5.03M $7.14M $5.21M $5.21M
Total Non-Current Assets $335.35M $335.54M $270.58M $273.43M $273.43M
Net PPE $504,000.00 $647,000.00 $785,000.00 $920,000.00 $920,000.00
-Gross PPE $504,000.00 $647,000.00 $785,000.00 $920,000.00 $920,000.00
Goodwill and Other Intangible Assets $94.59M $93.88M $24.16M $24.75M $24.75M
Non-Current Deferred Assets $234.53M $238.07M $243.28M $245.85M $245.85M
Other Non-Current Assets $5.74M $2.94M $2.36M $1.91M $1.91M
Total Liabilities $78.77M $95.64M $104.71M $122.11M $122.11M
Total Current Liabilities $78.77M $95.59M $89.49M $99.24M $99.24M
Payables $11.44M $4.01M $4.49M $7.19M $7.19M
-Accounts Payable $11.44M $4.01M $4.49M $7.19M $7.19M
Current Accrued Expenses $22.60M $14.88M $15.42M $15.64M $15.64M
Short-Term Debt and Capital Lease Obligation $7.79M $39.89M $30.50M $30.43M $30.43M
-Current Debt $7.24M $39.24M $29.87M $29.81M $29.81M
-Current Capital Lease Obligation $556,000.00 $656,000.00 $636,000.00 $614,000.00 $614,000.00
Current Deferred Liabilities $26.81M $27.97M $28.08M $29.07M $29.07M
Total Non-Current Liabilities $0.00 $58,000.00 $15.22M $22.88M $22.88M
Long Term Debt and Capital Lease Obligation $0.00 $58,000.00 $15.22M $22.88M $22.88M
-Long Term Capital Lease Obligation $0.00 $58,000.00 $228,000.00 $395,000.00 $395,000.00
Total Equity $445.11M $425.42M $399.90M $391.48M $391.48M
Stockholders' Equity $445.11M $425.42M $399.90M $391.48M $391.48M
Capital Stock $19,000.00 $18,000.00 $18,000.00 $18,000.00 $18,000.00
-Common Stock $19,000.00 $18,000.00 $18,000.00 $18,000.00 $18,000.00
Additional Paid-In Capital $1.43B $1.42B $1.41B $1.41B $1.41B
Retained Earnings -$983.91M -$997.10M -$1.01B -$1.02B -$1.02B
Gains/Losses Not Affecting Retained Earnings -$308,000.00 -$148,000.00 -$128,000.00 $181,000.00 $181,000.00
Other Current Liabilities – $218,000.00 $5.00M $5.00M $5.00M
-Long Term Debt – – $14.99M $22.48M $22.48M
-Preferred Stock – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $34.56M $30.65M $2.73M $75.66M $21.98M
Net cash flow from continuing operations $34.56M $30.65M $2.73M $75.66M $21.98M
Net Income from Continuing Operations $13.19M $17.29M $8.65M $367.02M $268.07M
Gain/Loss from Continuing Operations $0.00 – – – –
Depreciation & Depletion & Amortization $1.79M $848,000.00 $597,000.00 $2.42M $601,000.00
Deferred Tax $3.54M $5.21M $2.57M -$245.85M -$245.85M
Change in Working Capital $11.23M $286,000.00 -$12.39M -$19.51M -$3.34M
-Change in Receivables -$417,000.00 -$6.10M $1.82M -$10.15M -$5.84M
-Change in Inventory -$4.18M -$3.26M -$581,000.00 -$5.64M $1.13M
-Change in Prepaid Assets $2.84M $5.97M -$3.79M -$11.85M -$3.39M
-Change in Payables and Accrued Expense $12.65M $1.19M -$4.28M $5.30M $5.51M
-Change in Other Current Assets $143,000.00 $138,000.00 $135,000.00 -$674,000.00 $130,000.00
-Change in Other Current Liabilities -$158,000.00 -$150,000.00 -$145,000.00 $439,000.00 -$426,000.00
-Change In Other Working Capital $352,000.00 $2.50M -$5.54M $3.05M -$455,000.00
Net cash flow from investing -$18.45M $17.45M -$7.98M -$92.37M -$25.36M
Net Cash Flow from Continuing Investing Activities -$18.45M $17.45M -$7.98M -$92.37M -$25.36M
Net Intangibles Purchase and Sale -$217,000.00 – – $0.00 $0.00
Net Investment Purchase and Sale -$18.23M $87.80M -$7.98M -$92.37M -$25.37M
Financing Cash Flow -$30.29M -$11.70M -$10.92M $601,000.00 -$4.57M
Net Cash Flow from Continuing Financing Activities -$30.29M -$11.70M -$10.92M $601,000.00 -$4.57M
Net Issuance Payments Of Debt -$32.00M -$7.75M -$7.50M -$7.50M -$7.50M
Net Common Stock Issuance -$6.02M -$511,000.00 -$3.74M $0.00 $0.00
Proceeds from Stock Option Exercised $2.78M $1.86M $321,000.00 $8.10M $2.93M
Net Other Financing Charges $4.96M – – – –
Ending Cash Balance $46.70M $60.87M $24.47M $40.64M $40.64M
Net Change in Cash -$14.17M $36.41M -$16.17M -$16.11M -$7.95M
Beginning Cash Balance $60.87M $24.47M $40.64M $56.75M $48.59M
Free Cash Flow $34.35M -$39.69M $2.73M $75.66M $21.99M
Other Non-Cash Items – – – -$39.98M $0.00
Capital Expenditure – – – $0.00 $12,000.00
Net PPE Purchase and Sale – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on RIGL.

Sign in to join the discussion.

Scroll to Top